Neoadjuvant and Adjuvant Chemotherapy of Cervical Cancer
McCaffrey R, Bahtiyar M, Kohorn EI, Chambers JT, Schwartz PE, Chambers SK. Neoadjuvant and Adjuvant Chemotherapy of Cervical Cancer. International Journal Of Gynecological Cancer 2011, 21: 535-544. PMID: 21436702, DOI: 10.1097/igc.0b013e31820c4c8d.Peer-Reviewed Original ResearchMeSH KeywordsAdenocarcinomaAdultAntineoplastic Combined Chemotherapy ProtocolsBleomycinCarcinoma, AdenosquamousCarcinoma, Squamous CellChemotherapy, AdjuvantCisplatinFemaleFluorouracilHumansLeucovorinMaximum Tolerated DoseMethotrexateMiddle AgedNeoadjuvant TherapyNeoplasm Recurrence, LocalNeoplasm StagingProspective StudiesSurvival RateTreatment OutcomeUterine Cervical NeoplasmsYoung AdultConceptsLymph nodesRadiation therapyResponse rateSurvival ratePathologic complete response rateCisplatin-based neoadjuvant chemotherapyAdjuvant chemotherapy armComplete response rateConsolidation radiation therapyStage IIB cancerDisease-free survivalHigh-risk featuresPercent of patientsPositive lymph nodesPostoperative radiation therapyChemotherapy response rateAdjuvant casesAdjuvant chemotherapyChemotherapy armChemotherapy eraNeoadjuvant groupNonsquamous histologyNeoadjuvant chemotherapyAdjuvant groupOverall survival